Nucleotide excision repair deficiency is a targetable therapeutic vulnerability in clear cell renal cell carcinoma

Mostrar otras versiones (1)

PURPOSE: Due to a demonstrated lack of DNA repair deficiencies, clear cell renal cell carcinoma (ccRCC) has not benefitted from targeted synthetic lethality-based therapies. We investigated whether nucleotide excision repair (NER) deficiency is present in an identifiable subset of ccRCC cases that w...

Descripción completa

Detalles Bibliográficos
Autores principales: Prosz, Aurel, Duan, Haohui, Tisza, Viktoria, Sahgal, Pranshu, Topka, Sabine, Klus, Gregory T, Börcsök, Judit, Sztupinszki, Zsofia, Hanlon, Timothy, Diossy, Miklos, Vizkeleti, Laura, Stormoen, Dag Rune, Csabai, Istvan, Pappot, Helle, Vijai, Joseph, Offit, Kenneth, Ried, Thomas, Sethi, Nilay, Mouw, Kent W., Spisak, Sandor, Pathania, Shailja, Szallasi, Zoltan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9934582/
https://www.ncbi.nlm.nih.gov/pubmed/36798363
http://dx.doi.org/10.1101/2023.02.07.527498

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9934582/
https://www.ncbi.nlm.nih.gov/pubmed/36798363
http://dx.doi.org/10.1101/2023.02.07.527498

Ejemplares similares